An Evaluation of a Flippin' Pain Seminar Series

February 1, 2023 updated by: Dr Sophie Suri, Teesside University

An Evaluation of the Flippin' Pain Seminar Series: a Chronic Pain Education Campaign

The goal of this study is to evaluate a chronic pain seminar series, Flippin' Pain. The primary aim is to examine the impact of the seminars on attendees' beliefs and perceptions of the following with regards to chronic pain: medications, surgery, physical activity, and scans. A secondary aim is to examine attendees' experience of the seminar events. Seminar attendees included people with chronic pain and on an NHS waiting list for treatment, people with chronic pain and not on an NHS waiting list for treatment, healthcare professionals and non-healthcare professionals without chronic pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Chronic pain is defined as pain that continues for more than twelve weeks despite treatment. Chronic pain can be highly debilitating and have a devastating impact on an individual's mental and physical health and social aspects of their life. Poor understanding of chronic pain is widespread and can greatly reduce a) an individual's ability to manage their condition and b) the clinician's ability to treat the condition successfully. Educational interventions are therefore recommended. Flippin' Pain is a public health campaign that aims to improve understanding of chronic pain.

In February/March 2022, as part of the Flippin' Pain campaign, the Scottish government and NHS contracted Connect Health (TM) to deliver a series of 3 seminars in Scotland focused on pain science education. It was part of the Scottish Government 'Waiting Well' initiative and specifically targeted people on waiting lists for pain and musculoskeletal services in Scotland, although non-NHS individuals could also join including health professionals. Everyone who attended the seminars was asked if they would be happy to be contacted by the organisers as part of an evaluation of this event series.

Evaluation questionnaires were completed by 442 participants. This study will therefore be a secondary data analysis of this anonymous questionnaire data set to a). examine the impact of the seminars on attendees' beliefs and perceptions of chronic pain focusing on views towards medications, surgery, physical activity, and scans, and b). examine attendees' experience of the seminar events themselves.

The quantitative data collected from the questionnaires will be analysed using descriptive statistics. The qualitative free-text data collected from the questionnaires will be analysed using thematic analysis following Braun and Clarke's Framework.

Study Type

Observational

Enrollment (Actual)

442

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

i) People with chronic pain and on an NHS waiting list for treatment. ii) People with chronic pain and not on an NHS waiting list for treatment. iii) Healthcare professionals. iv) Non-healthcare professionals without chronic pain.

Description

Inclusion Criteria:

  • All individuals who took part in the seminar series, answered yes to this question posed on sign-up to the seminars - 'Would you be happy to be contacted by the organisers as part of evaluation of this event series, to take part in further research into chronic pain or to provide feedback on the Flippin' Pain campaign?' and completed the evaluation questionnaire will be included in this evaluation.

Exclusion Criteria:

  • Anyone who answered no to the question: 'Would you be happy to be contacted by the organisers as part of evaluation of this event series, to take part in further research into chronic pain or to provide feedback on the Flippin' Pain campaign?' provided on sign-up for the seminars will not be included in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attendees' at a Flippin' Pain seminar series beliefs and perceptions of the following with regards to chronic pain - medications, surgery, physical activity, and scans.
Time Frame: 1-2 days post event
Measured using a webinar evaluation questionnaire
1-2 days post event

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attendees' experience of a Flippin' Pain seminar series event.
Time Frame: 1-2 days post event
Measured using a webinar evaluation questionnaire
1-2 days post event

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Teesside University

Collaborators

Connect Health Ltd

Investigators

  • Principal Investigator: Sophie V Suri, PhD, Teesside University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 15, 2022

Primary Completion (ACTUAL)

March 23, 2022

Study Completion (ACTUAL)

April 1, 2022

Study Registration Dates

First Submitted

January 20, 2023

First Submitted That Met QC Criteria

February 1, 2023

First Posted (ACTUAL)

February 13, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 13, 2023

Last Update Submitted That Met QC Criteria

February 1, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2023 Jan 11120 Suri

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

All data will be anonymous.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Flippin' Pain Seminar Series

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe